Show simple item record

dc.contributor.authorPihtili, Aylin
dc.contributor.authorCagatay, Tulin
dc.contributor.authorGulbaran, Ziya
dc.contributor.authorKilicaslan, Zeki
dc.contributor.authorIssever, Halim
dc.contributor.authorGALLE, Michael
dc.contributor.authorÇUHADAROĞLU, Çağlar
dc.contributor.authorErkan, Feyza
dc.date.accessioned2021-03-03T17:01:05Z
dc.date.available2021-03-03T17:01:05Z
dc.date.issued2014
dc.identifier.citationPihtili A., GALLE M., ÇUHADAROĞLU Ç., Kilicaslan Z., Issever H., Erkan F., Cagatay T., Gulbaran Z., "Evidence for the Efficacy of a Bioresonance Method in Smoking Cessation: A Pilot Study", FORSCHENDE KOMPLEMENTARMEDIZIN, cilt.21, sa.4, ss.239-245, 2014
dc.identifier.issn1661-4119
dc.identifier.othervv_1032021
dc.identifier.otherav_477b7e43-aee7-4d03-b90a-c7995543afde
dc.identifier.urihttp://hdl.handle.net/20.500.12627/51608
dc.identifier.urihttps://doi.org/10.1159/000365742
dc.description.abstractBackground: Since the 1970s, MORA bioresonance therapy has globally been applied in the context of complementary medicine for various indications. In this regard, practitioners also report successful application in smoking cessation. The present study aims to verify these reports in a controlled study setting. Methods: In order to achieve the aforementioned objective, we subjected the bioresonance method to a prospective, placebocontrolled, double-blind, parallel-group study involving 190 smokers. In both study groups (placebo n = 95; active bioresonance group; n = 95) the course of treatment and study conditions were standardized. Results: 1 week (77.2% vs. 54.8%), 2 weeks (62.4% vs. 34.4%), 1 month (51.1% vs. 28.6%), and 1 year (28.6% vs. 16.1%) after treatment, the success rate in the verum group differed significantly from the results in the placebo group. Also, the subjective health condition after treatment and subjective assessment of efficacy, polled after 1 week, were significantly more positive among participants in the active bioresonance therapy group than among those in the placebo group. Adverse side effects were not observed. Conclusion: According to the findings attained by this pilot study, bioresonance therapy is clinically effective in smoking cessation and does not show any adverse side effects.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectENTEGRE VE TAMAMLAYICI TIP
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.titleEvidence for the Efficacy of a Bioresonance Method in Smoking Cessation: A Pilot Study
dc.typeMakale
dc.relation.journalFORSCHENDE KOMPLEMENTARMEDIZIN
dc.contributor.departmentInst Biophys Med , ,
dc.identifier.volume21
dc.identifier.issue4
dc.identifier.startpage239
dc.identifier.endpage245
dc.contributor.firstauthorID17512


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record